Redmile Group LLC 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 15,669,217 16.200% |
340,900 (+2.22%) |
Filing |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 15,328,317 18.800% |
1,763,068 (+13.00%) |
Filing |
| 2023-02-10 5:18 pm Purchase |
2022-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 13,565,249 16.800% |
6,114,220 (+82.06%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 7,451,029 9.700% |
692,235 (+10.24%) |
Filing |
| 2021-02-16 4:05 pm Purchase |
2020-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 6,758,794 8.810% |
6,758,794 (New Position) |
Filing |